Reuters -- Medicines Co said it withdrew the European marketing application for its experimental antibiotic, oritavancin, after the European Medicines Agency indicated that another trial would be required before approval could be considered.
Reuters -- Medicines Co said it withdrew the European marketing application for its experimental antibiotic, oritavancin, after the European Medicines Agency indicated that another trial would be required before approval could be considered.
